WINTON GROUP Ltd Cuts Stock Holdings in Maximus, Inc. $MMS

WINTON GROUP Ltd reduced its position in shares of Maximus, Inc. (NYSE:MMS) by 49.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 34,404 shares of the health services provider’s stock after selling 33,541 shares during the period. WINTON GROUP Ltd’s holdings in Maximus were worth $2,970,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the company. Total Wealth Planning & Management Inc. purchased a new stake in Maximus during the 4th quarter worth approximately $479,000. State of Wyoming increased its stake in Maximus by 6.9% during the 4th quarter. State of Wyoming now owns 10,704 shares of the health services provider’s stock worth $924,000 after buying an additional 687 shares in the last quarter. Sivia Capital Partners LLC increased its stake in Maximus by 14.1% during the 4th quarter. Sivia Capital Partners LLC now owns 3,308 shares of the health services provider’s stock worth $286,000 after buying an additional 408 shares in the last quarter. 1492 Capital Management LLC increased its stake in Maximus by 43.5% during the 4th quarter. 1492 Capital Management LLC now owns 3,776 shares of the health services provider’s stock worth $326,000 after buying an additional 1,144 shares in the last quarter. Finally, Goldman Sachs Group Inc. increased its stake in Maximus by 218.4% during the 4th quarter. Goldman Sachs Group Inc. now owns 583,627 shares of the health services provider’s stock worth $50,379,000 after buying an additional 400,315 shares in the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Jan Madsen sold 742 shares of the company’s stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total value of $53,609.50. Following the transaction, the director directly owned 20,795 shares in the company, valued at approximately $1,502,438.75. This represents a 3.45% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.80% of the company’s stock.

Wall Street Analyst Weigh In

MMS has been the subject of a number of analyst reports. Weiss Ratings lowered Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Zacks Research lowered Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Finally, Wall Street Zen upgraded Maximus from a “hold” rating to a “buy” rating in a research report on Saturday. Two investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Maximus has an average rating of “Hold”.

Maximus Price Performance

MMS stock opened at $60.49 on Monday. The company has a debt-to-equity ratio of 0.87, a current ratio of 2.21 and a quick ratio of 2.21. The business has a 50 day simple moving average of $63.79 and a 200-day simple moving average of $76.60. The firm has a market capitalization of $3.18 billion, a PE ratio of 9.06 and a beta of 0.58. Maximus, Inc. has a 1 year low of $56.92 and a 1 year high of $100.00.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, May 7th. The health services provider reported $2.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.98 by $0.09. The business had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.32 billion. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The business’s revenue was down 4.1% compared to the same quarter last year. During the same period in the prior year, the business earned $2.01 earnings per share. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. Equities research analysts anticipate that Maximus, Inc. will post 8.43 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were issued a $0.33 dividend. The ex-dividend date was Friday, May 15th. This represents a $1.32 dividend on an annualized basis and a yield of 2.2%. Maximus’s dividend payout ratio is currently 19.76%.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.